US20180016605A1 - Biomass of the microalgae schizochytrium mangrovei and method for preparing same - Google Patents

Biomass of the microalgae schizochytrium mangrovei and method for preparing same Download PDF

Info

Publication number
US20180016605A1
US20180016605A1 US15/722,563 US201715722563A US2018016605A1 US 20180016605 A1 US20180016605 A1 US 20180016605A1 US 201715722563 A US201715722563 A US 201715722563A US 2018016605 A1 US2018016605 A1 US 2018016605A1
Authority
US
United States
Prior art keywords
biomass
dha
weight
expressed
fatty acids
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
US15/722,563
Inventor
Serge Comini
Bernard Pora
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Roquette Freres SA
Original Assignee
Roquette Freres SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roquette Freres SA filed Critical Roquette Freres SA
Priority to US15/722,563 priority Critical patent/US20180016605A1/en
Publication of US20180016605A1 publication Critical patent/US20180016605A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23D—EDIBLE OILS OR FATS, e.g. MARGARINES, SHORTENINGS, COOKING OILS
    • A23D9/00—Other edible oils or fats, e.g. shortenings, cooking oils
    • A23D9/007—Other edible oils or fats, e.g. shortenings, cooking oils characterised by ingredients other than fatty acid triglycerides
    • A23D9/013—Other fatty acid esters, e.g. phosphatides
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K20/00—Accessory food factors for animal feeding-stuffs
    • A23K20/10—Organic substances
    • A23K20/158—Fatty acids; Fats; Products containing oils or fats
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
    • A23L33/115—Fatty acids or derivatives thereof; Fats or oils
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/02—Nutrients, e.g. vitamins, minerals
    • C—CHEMISTRY; METALLURGY
    • C11—ANIMAL OR VEGETABLE OILS, FATS, FATTY SUBSTANCES OR WAXES; FATTY ACIDS THEREFROM; DETERGENTS; CANDLES
    • C11B—PRODUCING, e.g. BY PRESSING RAW MATERIALS OR BY EXTRACTION FROM WASTE MATERIALS, REFINING OR PRESERVING FATS, FATTY SUBSTANCES, e.g. LANOLIN, FATTY OILS OR WAXES; ESSENTIAL OILS; PERFUMES
    • C11B1/00—Production of fats or fatty oils from raw materials
    • C11B1/10—Production of fats or fatty oils from raw materials by extracting
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/12—Unicellular algae; Culture media therefor
    • C12N1/125—Unicellular algae isolates
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6409—Fatty acids
    • C12P7/6427—Polyunsaturated fatty acids [PUFA], i.e. having two or more double bonds in their backbone
    • C12P7/6434—Docosahexenoic acids [DHA]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P7/00—Preparation of oxygen-containing organic compounds
    • C12P7/64—Fats; Fatty oils; Ester-type waxes; Higher fatty acids, i.e. having at least seven carbon atoms in an unbroken chain bound to a carboxyl group; Oxidised oils or fats
    • C12P7/6436—Fatty acid esters
    • C12P7/6445—Glycerides
    • C12P7/6463—Glycerides obtained from glyceride producing microorganisms, e.g. single cell oil
    • C12R1/89—
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
    • A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/89—Algae ; Processes using algae

Definitions

  • the present invention relates to a biomass of microalgae which is rich in docosahexaenoic acid (or DHA), palmitic acid and phospholipids, in particular phosphatidylcholine, biomass of microalgae of the Thraustochytrium genus, more particularly Schizochytrium, in the case in point the biomass of a particular strain of Schizochytrium mangrovei.
  • DHA docosahexaenoic acid
  • palmitic acid and phospholipids, in particular phosphatidylcholine
  • biomass of microalgae of the Thraustochytrium genus, more particularly Schizochytrium in the case in point the biomass of a particular strain of Schizochytrium mangrovei.
  • Lipids constitute one of the three major families of macronutrients, along with proteins and carbohydrates.
  • lipids triglycerides and phospholipids in particular stand out:
  • Triglycerides represent approximately 95% of the dietary lipids ingested by human beings. In the body, they are present mainly in adipose tissues and constitute the main form of energy storage.
  • Phospholipids are structural lipids since they are constituents of cell membranes of which they provide, inter alia, the fluidity.
  • phospholipids are phosphoglycerides, the head of which is organized around a glycerol-3-phosphate residue esterified with a polar molecule, and the two tails of which are the aliphatic chains of two fatty acids.
  • the other phospholipids are sphingomyelins, which derive structurally from sphingosine and not from glycerol, sphingosine constituting one of the two aliphatic tails.
  • the first phospholipids isolated from live tissues were characterized from egg yolk lecithin; they were more particularly phosphatidylcholines. This is, moreover, why phosphatidylcholines are also known as lecithins.
  • Phosphatidylcholines are naturally produced by the liver. They are an important constituent of bile, in which they emulsify the fats present in the duodenum. They are also necessary, in addition to bile salts, for preventing lipid droplets from re-agglutinating.
  • phosphatidylcholines participate in the membranes of cells and serve to preserve their viscoelasticity. They are an essential component of the nervous system and constitute close to 30% of the dry weight of the brain and 15% of the nerves.
  • Triglycerides and phospholipids are composed predominantly of fatty acids which are both provided by the diet and, for some of them, synthesized by the organism.
  • the biochemical classification (based on the number of double bonds contained in the fatty acid molecule) distinguishes saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs).
  • SFAs saturated fatty acids
  • MUFAs monounsaturated fatty acids
  • PUFAs polyunsaturated fatty acids
  • the set of indispensible and “conditionally” indispensible fatty acids constitutes the essential fatty acids.
  • the other fatty acids are termed non-essential.
  • non-indispensible fatty acids are, in particular:
  • Polyunsaturated fatty acids are classified according to the position of the first double bond, starting from the final methyl function.
  • omega 6 fatty acids or n-6 PUFAs
  • LA linoleic acid
  • omega 3 fatty acids or n-3 PUFAs
  • ALA alpha-linolenic acid
  • the majority of the polyunsaturated fatty acids of biological interest belong to the omega 6 family (arachidonic acid or ARA) or omega 3 family (eicosapentaenoic acid or EPA, docosahexaenoic acid or DHA).
  • the “5” and “6” thus correspond to the number of unsaturations of the carbon chain presented respectively by EPA and by DHA.
  • DHA of the omega 3 fatty acid family, is a fatty acid that the organism can synthesize from alpha-linolenic acid, or which is provided by the consumption of oily fish (tuna, salmon, herring, etc.).
  • DHA plays an important role in the structure of membranes and in the development and function of the brain and retina.
  • Fish oils are used mainly as a source of omega 3 fatty acids, such as DHA and EPA, but they are also found in oils of microalgae where they are extracted either as a mixture, or separately, as is the case for example with the oils derived from certain selected strains, such as those of the Schizochytrium genus, which contain only traces of EPA but have high DHA contents.
  • the applicant has first of all provided a novel biomass of microalgae, rich in DHA, having:
  • Palmitic acid also called hexadecanoic acid or cetyl acid, is one of the most common C16:0 saturated fatty acids in animals and plants.
  • Palmitic acid is the first fatty acid produced during lipogenesis; longer fatty acids can be produced from said palmitic acid.
  • the fatty acid preferentially used to synthesize ATP.
  • the energy balance of the combustion thereof indicates 129 ATP. It thus constitutes an excellent energy food.
  • palmitic acid is also used for the production of margarines and hard soaps.
  • palmitic acid In the paint field, given that it is saturated, palmitic acid cannot polymerize and becomes rigid once in contact with atmospheric oxygen (unlike oleic acid, linoleic acid and linolenic acid). It therefore remains in its soft solid form and acts (with stearic acid) as a plasticizer for polymerized oily binders. Thus, with stearic acid, it provides the elasticity required for good preservation of oil-containing pictorial materials over time.
  • the biomass of Schizochytrium mangrovei according to the invention has:
  • the present invention relates to the strain of Schizochytrium mangrovei deposited on Nov. 22, 2012 at the CNCM under number I-4702.
  • the present invention also relates to a variant of this strain or to a strain derived therefrom, said variant or said derived strain conserving the property of producing high contents of DHA and palmitic acid.
  • the mutagenesis may be site-directed and/or random.
  • This strain conserves the property of producing high contents of DHA and palmitic acid.
  • it is capable of producing more than 35% of DHA and more than 40% of palmitic acid, these two % being expressed by weight of total fatty acids, in particular when it is cultured under the conditions described in example 1.
  • it produces between 1 and 1.3% of phosphatidylcholine, expressed by weight of biomass at 99% of dry matter.
  • the present invention also relates to a method of preparing such a strain, comprising the mutagenesis or gene transformation of the CNCM I-4702 strain and optionally a screening step for selecting the strains producing:
  • the invention relates to a method of culturing the CNCM I-4702 strain or a variant thereof conserving the capacity for producing DHA and palmitic acid, comprising a step of culturing this strain in an appropriate medium, in suitable fermentation conditions.
  • the invention relates to a method for preparing the biomass of Schizochytrium mangrovei , characterized in that it is prepared by the sequence of the following steps:
  • the culturing is carried out in heterotrophic conditions.
  • the culturing step comprises a preculturing step, in order to revive the strain, then a step of culturing or fermentation proper. This latter step corresponds to the step of producing the lipid compounds of interest.
  • the applicant recommends, for the CNCM I-4702 strain, carrying out a three-step aerobic fermentation, as will be exemplified hereinafter.
  • the three fermentation steps are characterized by culturing the CNCM I-4702 strain in a medium in which the provision of carbon sources is regulated according to the glucose consumption by the microorganism.
  • the present invention subsequently relates to the recovery, at the end of fermentation, of the biomass rich in lipid compounds of interest, in this case DHA and palmitic acid.
  • the biomass is:
  • the biomass may contain:
  • the present invention relates to the use of the biomass rich in DHA, palmitic acid and phosphatidylcholine produced by any one of the methods of the present invention, in the preparation of compositions intended for the food sector, in particular animal nutrition, but also human nutrition.
  • compositions intended for the food sector comprising the production of a biomass rich in DHA, palmitic acid and phosphatidylcholine by any one of the methods of the present invention, then the preparation of compositions intended for the food sector.
  • the present invention relates in particular to a product or a composition comprising the CNCM I-4702 strain or a variant thereof conserving the capacity of producing DHA, and a biomass obtained after culturing or fermentation thereof.
  • this product or composition is a food composition or a food or nutritional supplement.
  • It may be in liquid or solid form.
  • This product or composition may be in powder, granule, gel capsule, capsule or tablet form, preferably in powder form.
  • compositions of the culture media and the fermentation conditions are given in the following tables.
  • the initial glucose concentration in the sterilized culture medium of the 10 m 3 fermenter is fixed at 15 to 16 g/I.
  • the principle for feeding with glucose during the fermentation in 10 m 3 is the following:
  • the level of lipid accumulation and the level of DHA production gradually increase and reach a maximum at 72 hours.
  • the recovery of the cells is therefore optimal as soon as this fermentation time is reached.
  • the biomass recovered at the end of the fermentation described in example 1 has the following composition:
  • the biomass recovered is centrifuged a first time at 6000 g, and the cells recovered are then diluted in sterile water (1.5/1 ratio) and then centrifuged a second time.
  • composition of the dried biomass is the following (Table 8):
  • the fatty acids were determined by gas chromatography in the form of methyl esters after transesterification with methanolic hydrochloric acid and extraction with chloroform. The results are expressed as % distribution; the analysis is carried out by the internal standardization method.
  • a chromatograph (Varian 3800) equipped with a split-splitless injector with a tapfocus liner and a flame ionization detector was used.
  • the % distribution of each fatty acid (i) was obtained by the ratio of the area of the peak of this fatty acid relative to the sum of the areas of all the peaks pinpointed on the chromatogram, from lauric acid (C12:0) to DHA (C22:6 ⁇ 4c, 7c, 10c, 13c, 16c, 19c) inclusive, with the methyl heptadecanoate peak being excluded.
  • the phospholipids are analyzed after disruption and cold extraction of the biomass, carried out under the following conditions.
  • the boat is placed in a Pyrex NMR tube 5 mm in diameter along with 0.9 ml of methanol and 2 ml of chloroform.
  • the tube is hermetically closed and stirred by means of a vortex mixer for 1 min.
  • the tube is placed in the refrigerator. After settling out (minimum of 1 hour), the clear upper phase is carefully recovered and is transferred into a glass jar for evaporation to dryness, at ambient temperature, under a nitrogen stream.
  • the solid extract is dissolved in 0.5 ml of CDCl 3 and 0.1 ml of CD 3 OD and transferred into an NMR tube.
  • the phosphorus provided by the four main phospholipids is taken into account and oleic acid is used to calculate the molar mass of each of them.
  • the phospholipid content is equal to the sum of the amounts of these four phospholipids thus calculated.
  • the biomasses analyzed according to these methods are biomasses sold by Aquafauna Bio-Marine Inc., DSM/Martek and New Horizon.

Landscapes

  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Microbiology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Polymers & Plastics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Botany (AREA)
  • Nutrition Science (AREA)
  • Animal Husbandry (AREA)
  • Mycology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fats And Perfumes (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

The invention concerns a strain of Shizochytrium mangrovei filed on 22 Nov. 2012 with the CNCM as number 1-4702 having the ability to produce a high quantity of docosahexaenoic acid (or DHA) and palmitic acid, the methods for producing the corresponding biomass containing said lipid compounds of interest, and the biomass containing the products and compositions prepared from this strain.

Description

    CROSS-REFERENCE TO RELATED APPLICATION
  • This application is the U.S. national stage application of International Patent Application No. PCT/EP2014/052214, filed Feb. 5, 2014.
  • The Sequence Listing for this application is labeled “Seq-List.txt” which was created on Jul. 17, 2015 and is 1 KB. The entire contents of the sequence listing is incorporated herein by reference in its entirety.
  • The present invention relates to a biomass of microalgae which is rich in docosahexaenoic acid (or DHA), palmitic acid and phospholipids, in particular phosphatidylcholine, biomass of microalgae of the Thraustochytrium genus, more particularly Schizochytrium, in the case in point the biomass of a particular strain of Schizochytrium mangrovei.
  • Lipids constitute one of the three major families of macronutrients, along with proteins and carbohydrates.
  • Among the lipids, triglycerides and phospholipids in particular stand out:
      • Triglycerides (also called triacylglycerols, triacylglycerides or TAGs) are glycerides in which the three hydroxyl groups of glycerol are esterified with fatty acids. They are the main constituent of vegetable oil and animal fats.
  • Triglycerides represent approximately 95% of the dietary lipids ingested by human beings. In the body, they are present mainly in adipose tissues and constitute the main form of energy storage.
      • Phospholipids are amphiphilic lipids, i.e., lipids consisting of a polar (hydrophilic) “head” and two aliphatic (hydrophobic) “tails”.
  • Phospholipids are structural lipids since they are constituents of cell membranes of which they provide, inter alia, the fluidity.
  • Most phospholipids are phosphoglycerides, the head of which is organized around a glycerol-3-phosphate residue esterified with a polar molecule, and the two tails of which are the aliphatic chains of two fatty acids.
  • The other phospholipids are sphingomyelins, which derive structurally from sphingosine and not from glycerol, sphingosine constituting one of the two aliphatic tails.
  • The first phospholipids isolated from live tissues were characterized from egg yolk lecithin; they were more particularly phosphatidylcholines. This is, moreover, why phosphatidylcholines are also known as lecithins.
  • Phosphatidylcholines are naturally produced by the liver. They are an important constituent of bile, in which they emulsify the fats present in the duodenum. They are also necessary, in addition to bile salts, for preventing lipid droplets from re-agglutinating.
  • As phospholipids, phosphatidylcholines participate in the membranes of cells and serve to preserve their viscoelasticity. They are an essential component of the nervous system and constitute close to 30% of the dry weight of the brain and 15% of the nerves.
  • Triglycerides and phospholipids are composed predominantly of fatty acids which are both provided by the diet and, for some of them, synthesized by the organism.
  • The biochemical classification (based on the number of double bonds contained in the fatty acid molecule) distinguishes saturated fatty acids (SFAs), monounsaturated fatty acids (MUFAs) and polyunsaturated fatty acids (PUFAs).
  • From the physiological point of view, the following are distinguished:
      • indispensible fatty acids, required for development and correct functioning of the human body, but which the body is not able to produce;
      • “conditionally” indispensible fatty acids, which are essential for normal growth and the physiological functions of cells, but which can be produced from their precursor if it is provided by the diet, and which are therefore rigorously required if their indispensible precursor is absent; and
      • non-indispensible fatty acids.
  • The set of indispensible and “conditionally” indispensible fatty acids constitutes the essential fatty acids.
  • The other fatty acids are termed non-essential.
  • Among the non-indispensible fatty acids are, in particular:
      • eicosapentaenoic acid (EPA) of the omega 3 fatty acid family,
      • oleic acid, the predominant monounsaturated fatty acid in our diet, and
      • saturated fatty acids, such as lauric acid, myristic acid or palmitic acid.
  • Polyunsaturated fatty acids are classified according to the position of the first double bond, starting from the final methyl function.
  • Thus, in the nomenclature, for omega “x” or “nx”, “x” corresponds to the position of the first unsaturation.
  • Two major families of essential fatty acids are distinguished: omega 6 fatty acids (or n-6 PUFAs), of which the precursor and the major representative is linoleic acid (LA), and omega 3 fatty acids (or n-3 PUFAs), of which the precursor is alpha-linolenic acid (ALA).
  • The majority of the polyunsaturated fatty acids of biological interest belong to the omega 6 family (arachidonic acid or ARA) or omega 3 family (eicosapentaenoic acid or EPA, docosahexaenoic acid or DHA).
  • In addition, in the nomenclature, the carbon number constituting the chain is also defined: thus, EPA is described as C20:5 and DHA as C22:6.
  • The “5” and “6” thus correspond to the number of unsaturations of the carbon chain presented respectively by EPA and by DHA.
  • DHA, of the omega 3 fatty acid family, is a fatty acid that the organism can synthesize from alpha-linolenic acid, or which is provided by the consumption of oily fish (tuna, salmon, herring, etc.).
  • DHA plays an important role in the structure of membranes and in the development and function of the brain and retina.
  • Fish oils are used mainly as a source of omega 3 fatty acids, such as DHA and EPA, but they are also found in oils of microalgae where they are extracted either as a mixture, or separately, as is the case for example with the oils derived from certain selected strains, such as those of the Schizochytrium genus, which contain only traces of EPA but have high DHA contents.
  • Commercial preparations of biomasses of microalgae rich in DHA are available.
  • Mention may thus be made, for example, of:
      • products of the Algamac range, sold by Aquafauna Bio-Marine Inc., proposed for nutrition in rotifer aquaculture, or
      • products sold by DSM under the brand name DHA Gold™.
  • However, there remains a need to provide biomasses of microalgae of quality, with a high DHA content, and having entirely specific profiles of long-chain saturated or polyunsaturated fatty acids and phospholipids.
  • The applicant has first of all provided a novel biomass of microalgae, rich in DHA, having:
      • low contents of polyunsaturated fatty acids other than DHA (such as EPA),
      • a limited content of certain long-chain saturated fatty acids (such as myristic acid and lauric acid), and
      • a high content of phospholipids (up to double the amounts conventionally found in commercial preparations), more particularly of phosphatidylcholine.
  • Likewise anxious to develop a production process which is more efficient and much less expensive than those described in the prior art, the applicant has, during its research, identified a novel strain of Schizochytrium mangrovei which produces DHA and which has the particularity of producing:
      • very few hypercholesterolemic saturated fatty acids (less than 6% of lauric and myristic acids, which those skilled in the art know are the most hypercholesterolemic known), and
      • more than 40% of palmitic acid
  • (the % understood here to be by weight of total fatty acids).
  • Palmitic acid, also called hexadecanoic acid or cetyl acid, is one of the most common C16:0 saturated fatty acids in animals and plants.
  • Palmitic acid is the first fatty acid produced during lipogenesis; longer fatty acids can be produced from said palmitic acid.
  • Furthermore, it is the fatty acid preferentially used to synthesize ATP. The energy balance of the combustion thereof indicates 129 ATP. It thus constitutes an excellent energy food.
  • Industrially, palmitic acid is also used for the production of margarines and hard soaps.
  • In the paint field, given that it is saturated, palmitic acid cannot polymerize and becomes rigid once in contact with atmospheric oxygen (unlike oleic acid, linoleic acid and linolenic acid). It therefore remains in its soft solid form and acts (with stearic acid) as a plasticizer for polymerized oily binders. Thus, with stearic acid, it provides the elasticity required for good preservation of oil-containing pictorial materials over time.
  • Moreover, the biomass of Schizochytrium mangrovei according to the invention has:
      • a phospholipid content between 1.5 and 2%, 1 to 1.3% of which consists of phosphatidylcholine, and
      • a total amino acid content between 10 and 20% expressed as N×6.25 (the % being understood here to be by weight relative to 100 g of biomass at 99% of dry matter).
  • This strain of Schizochytrium mangrovei was deposited in France on Nov. 22, 2012 at the Collection Nationale de Cultures de Microorganismes [National Collection of Microorganism Cultures] of the Institut Pasteur (CNCM), 25 rue du docteur Roux, 75724 Paris Cedex 15, France, under number CNCM I-4702.
  • It was characterized by sequencing the genes encoding 18 S rRNA:
  • (SEQ ID NO: 1)
    1 GGTTTTACAT TGCTCTCATT CCGATAGCAA AACGCATACA
    CGCTTCGCAT CGATATTTCT
    61 CGTCCTACCT CGTGGAGTCC ACAGTGGGTA ATTTACGCGC
    CTGCTGCTAT CCTTGGATAT
    121 GGTAGCCGTC TCTCAGGCTC CCTCTCCGGA GTCGAGCCCT
    AACTCTCCGT CACCCGTTAT
    181 AGTCACCGTA GTCCAATACA CTACCGTCGA CAACTGATGG
    GGCAGAAACT CAAACGATTC
    241 ATCGACCAAA AWAGTCAATC TGCTCAATTA TCATGATTCA
    CCAATAAAAT CGGCTTCAAT
    301 CTAATAAGTG CAGCCCCATA CAGGGCTCTT ACAGCATGTA
    TTATTTCCAG AATTACTGCA
    361 GGTATCCATA TAAAAGAAAC TACCGAAGAA ATTATTACTG
    ATATAATGAG CCGTTCGCAG
    421 TCTCACAGTA CAATCGCTTA TACTTACACA GCAG

    which made it possible to identify it as being a strain of the Schizochytrium mangrovei type.
  • Consequently, the present invention relates to the strain of Schizochytrium mangrovei deposited on Nov. 22, 2012 at the CNCM under number I-4702.
  • This strain may subsequently be denoted “CNCM I-4702” in the present application.
  • The present invention also relates to a variant of this strain or to a strain derived therefrom, said variant or said derived strain conserving the property of producing high contents of DHA and palmitic acid.
  • In particular, it relates to a strain of Schizochytrium mangrovei obtained from the CNCM I-4702 strain by mutagenesis or by gene transformation. The mutagenesis may be site-directed and/or random. This strain conserves the property of producing high contents of DHA and palmitic acid. In particular, it is capable of producing more than 35% of DHA and more than 40% of palmitic acid, these two % being expressed by weight of total fatty acids, in particular when it is cultured under the conditions described in example 1. In addition, it produces between 1 and 1.3% of phosphatidylcholine, expressed by weight of biomass at 99% of dry matter.
  • The present invention also relates to a method of preparing such a strain, comprising the mutagenesis or gene transformation of the CNCM I-4702 strain and optionally a screening step for selecting the strains producing:
      • more than 35% of DHA,
      • more than 40% of palmitic acid (these two % expressed by weight of total fatty acids), and
      • between 1 and 1.3% of phosphatidylcholine (this % expressed by weight of biomass at 99% of dry matter).
  • The invention relates to a method of culturing the CNCM I-4702 strain or a variant thereof conserving the capacity for producing DHA and palmitic acid, comprising a step of culturing this strain in an appropriate medium, in suitable fermentation conditions.
  • Moreover, the invention relates to a method for preparing the biomass of Schizochytrium mangrovei, characterized in that it is prepared by the sequence of the following steps:
      • culturing the strain in heterotrophic conditions so as to produce a biomass having between 35 and 40% of DHA, expressed by weight of total fatty acids, between 40 and 50 wt% of palmitic acid, expressed by weight of total fatty acids, and between 1 and 1.3% of phosphatidylcholine, % expressed by weight of biomass,
      • collecting the biomass thus prepared,
      • drying said biomass.
  • The culturing is carried out in heterotrophic conditions. Generally, the culturing step comprises a preculturing step, in order to revive the strain, then a step of culturing or fermentation proper. This latter step corresponds to the step of producing the lipid compounds of interest.
  • The applicant recommends, for the CNCM I-4702 strain, carrying out a three-step aerobic fermentation, as will be exemplified hereinafter.
  • After a prior preculturing step, the three fermentation steps are characterized by culturing the CNCM I-4702 strain in a medium in which the provision of carbon sources is regulated according to the glucose consumption by the microorganism.
  • It is thus noted that the glucose consumption is consumed gradually in the first hours of fermentation, and then it remains constant until the end of fermentation, as will be exemplified hereinafter.
  • The present invention subsequently relates to the recovery, at the end of fermentation, of the biomass rich in lipid compounds of interest, in this case DHA and palmitic acid.
  • After the fermentation step, the biomass is:
      • pasteurized, so as to inactivate the lipid-degrading enzymes (lipases) present in the biomass as such, and also in the culture medium, and
      • recovered from the fermentation medium by any method known per se to those skilled in the art; for example, the biomass can be extracted from the fermenter and simply concentrated by microfiltration or centrifugation, or washed by a succession of concentrations/dilutions with an aqueous solution.
  • After fermentation, the biomass may contain:
      • between 35 and 40% of DHA, expressed by weight of total fatty acids,
      • between 40 and 50 wt% of palmitic acid, expressed by weight of total fatty acids, and
      • between 1.5 and 2% of phospholipids, 1 to 1.3% of which consists of phosphatidylcholine, % expressed by weight of biomass.
  • Finally, the present invention relates to the use of the biomass rich in DHA, palmitic acid and phosphatidylcholine produced by any one of the methods of the present invention, in the preparation of compositions intended for the food sector, in particular animal nutrition, but also human nutrition.
  • Thus, it relates to a method of preparing compositions intended for the food sector, comprising the production of a biomass rich in DHA, palmitic acid and phosphatidylcholine by any one of the methods of the present invention, then the preparation of compositions intended for the food sector.
  • The present invention relates in particular to a product or a composition comprising the CNCM I-4702 strain or a variant thereof conserving the capacity of producing DHA, and a biomass obtained after culturing or fermentation thereof.
  • Preferably, this product or composition is a food composition or a food or nutritional supplement.
  • It may be in liquid or solid form.
  • This product or composition may be in powder, granule, gel capsule, capsule or tablet form, preferably in powder form.
  • The invention will be understood more clearly by means of the examples which follow, which are meant to be illustrative and nonlimiting.
    • EXAMPLE 1 Production of a Biomass Rich in DHA and Palmitic Acid by the Schizochytrium mangrovei Strain CNCM I-4702
  • The compositions of the culture media and the fermentation conditions are given in the following tables.
  • TABLE 1
    Composition of the culture media
    Successive fermenters of:
    100 liters 1 m3 10 m3
    Effective volume of the fermenter
    70 liters 700 liters 7000 liters
    Glucose (kg) 6 41.3 1120
    Monosodium gluconate (kg) 4.494 26.67 /
    Liquid corn steep (kg) / / 119
    Yeast extracts (kg) 0.448 2.03 42
    NaCl (kg) 1.4 2.66 16.8
    KH2PO4 (kg) 0.448 2.80 33.6
    MgSO4 (kg) 1.6 7.35 42
    CaCl2 (kg) 0.02 0.14 4.2
    NaHCO3 (kg) 0.2 0.07 4.2
    Antifoam (kg) 0.112 1.12 11.2
    (DOW FAX DF 104)
    Na2SO4 (kg) 0.02 0.07 42
    Urea (kg) / / 18.9
    KCl (kg) / / 2.8
    Aqueous ammonia / / 33.6
    (28%, liter)
    “Red” liquid (liter) 0.098 0.98 14
    “Green” liquid (liter) 0.140 1.4 19.60
  • The initial glucose concentration in the sterilized culture medium of the 10 m3 fermenter is fixed at 15 to 16 g/I.
  • TABLE 2
    Parameters for control of the preculture and the 3 successive fermentations
    Preculture 100 liters 1 m3 10 m3
    Load volume 200 ml × 3 70 liters 0.7 m3 7 m3
    Temperature 28° C. 28° C. 28° C. 0-68 h: 28° C.
    (° C.) 68-80 h: 26° C.
    pH No No No regulation Regulation 6.2~6.6
    Air flow rate — 4.5-5.0 41-42 0-24 h: 95-105;
    (m3/h) 24-60 h: 50-60;
    60-80 h: 25-30
    Pressure (Mpa) — 0.025-0.03  0.025-0.03  0.03
    Shaking (rpm) 180 rpm 120-140 140 70-75
    Fermentation 48 24-48 24-48 ~80
    time (h)
  • The principle for feeding with glucose during the fermentation in 10 m3 is the following:
      • the concentration of the glucose feed solution is 50-60%, and
      • when the residual glucose concentration (RCS) decreases to 1 g/l before 48 h, a solution containing 0.65 g/l of glucose is fed in one step until the glucose is exhausted and the fermentation is complete.
  • The results of the various fermentations are given in the following tables.
  • TABLE 3
    First fermentation
    Time (h) 0 8 16 23
    pH 5.6 5.6 7.0 7.6
    Residual glucose 5.4 / / 4.7
    concentration (g/100 ml)
    Amino nitrogen 269 / / 123
    (mg/100 ml)
    Phosphorus (ppm) 692 / / 159.1
    Dry weight of cells ~0 / / 29
    (g/l)
  • TABLE 4
    Second fermentation
    Time (h)
    0 6 h 10 h 14 h 18 h 22 h 24 h
    pH 5.4 7.1 7.6 8.0  8.1 8.05 7.9
    Residual glucose 5.8 / / / / / 2.2
    concentration
    (g/100 ml)
    Amino nitrogen 166 / / / / / 75
    (mg/100 ml)
    Phosphorus (ppm) 725.8 / / / 141.2 / 86.7
    Dry weight of cells 1.6 / / / / / 46.7
    (g/l)
  • TABLE 5
    Third fermentation
    Time (h)
    0 12 24 36 48 60 64 72 81
    pH 6.7 6.3 5.8 6 6.2 6.45 6.5 6.5 6.6
    Residual 14.1 12.1 9.1 11.2 9.6 5.8 5.8 4.35 1.35
    glucose
    concentration
    (g/100 ml)
    Amino 165 84 53 36 35 39 / 37 31
    nitrogen
    (mg/100 ml)
    Air flow rate 95-100 m3/h 60 m3/h 30 m3/h
    (m3/h)
    Temperature 28 26
    (° C.)
    Phosphorus 724.1 692.4 661.3 544.3 599 659 / 651.2 618
    (ppm)
    Dry weight of 11.8 25.7 37.4 38.5 44.2 69.9 / 75.4 80.5
    cells
    (g/l)
    DHA content / / / 30.7 27.6 34 / 32.75 31.4
    (%)
  • Almost 70% of the amino nitrogen is consumed during the first 24 h of fermentation; the phosphorus is also consumed during the cell growth step and is no longer consumed subsequently (in connection with the regulation of the aeration flow rate and the fermentation temperature).
  • The level of lipid accumulation and the level of DHA production gradually increase and reach a maximum at 72 hours.
  • The recovery of the cells is therefore optimal as soon as this fermentation time is reached.
  • It is chosen to stop the fermentation at 81 h.
    • EXAMPLE 2 Recovery and Conditioning of the Biomass of the CNCM I-4702 Strain for Applications in Animal and Human Nutrition
  • The biomass recovered at the end of the fermentation described in example 1 has the following composition:
  • TABLE 6
    Volume
    recovered Dry weight of DHA content
    (m3) cells (g/l) (%)
    7.5 80.5 31.4
  • The biomass recovered is centrifuged a first time at 6000 g, and the cells recovered are then diluted in sterile water (1.5/1 ratio) and then centrifuged a second time.
  • It is then subjected to a heat treatment at 70° C. for 15 minutes.
  • 2.55 t of wet biomass (16.7% of dry matter) are recovered.
  • The following are added thereto for the formulations intended for animal nutrition:
      • 2% of maltodextrin with a DE (dextrose equivalent) of 18,
      • 0.5% of monoglycerides and diglycerides,
      • 1% of citric acid,
      • 0.2% of anthracyne 2727 (as antioxidant), and
      • 0.2% of tricalcium phosphate.
  • For the formulations intended for human nutrition, food-grade antioxidants of tocopherol type or extracts of rosemary are used.
  • This biomass is spray-dried in a single-stage spray dryer (conventional running known to those skilled in the art) in the conditions given in the following Table 7:
  • TABLE 7
    Parameters Values
    Solution temperature 65-70° C.
    Air input temperature 155-160° C.
    Air output temperature 75° C.-80° C.
    Pressure ~7.5 Mpa
    Wet biomass input (kg) 690.7
    Dry matter of the biomass (%) 16.7
    Theoretical weight of cells (kg) 115.35
    Weight of dry cells obtained (kg) 144.03
    Drying yield (%) 125
  • The composition of the dried biomass is the following (Table 8):
  • TABLE 8
    Parameters Values
    DHA content (% relative to total 35.2
    fatty acids)
    Proteins N6.25 in g/100 g crude 16.7
    Phospholipids (%) 1.6
    Residual water content (%) 1.2
    Ash (%) 6.4
    POV (meq/kg) 0.4
    P- Anisidine (%) 23.8
    • EXAMPLE 3 Comparative Study of the Lipid Profile of a Biomass in Accordance with the Invention Compared with those that are Commercially Available
  • The fatty acids were determined by gas chromatography in the form of methyl esters after transesterification with methanolic hydrochloric acid and extraction with chloroform. The results are expressed as % distribution; the analysis is carried out by the internal standardization method.
  • A chromatograph (Varian 3800) equipped with a split-splitless injector with a tapfocus liner and a flame ionization detector was used.
  • An internal standard solution containing about precisely 0.5 mg of methyl heptadecanoate per ml of methanol was prepared. The methyl heptadecanoate served as a chromatographic point of reference.
  • About precisely 30 mg of pre-dried sample were weighed into a 6 ml tube. 1 ml of the internal standard solution and then 2 ml of 3N methanolic hydrochloric acid were added using a pipette with two measurement lines. The tube was then stoppered and placed in a dry bath thermostated at 110° C. for 4 h.
  • After cooling, about 0.5 ml of water and 0.5 ml of saturated aqueous sodium chloride solution were added, and extraction was carried out with 3 times 1 ml of chloroform. The chloroform phases were recovered in a 6 ml tube with them being dried on a column containing sodium sulfate. They were concentrated under a nitrogen stream to about 1 ml and injected.
  • The % distribution of each fatty acid (i) was obtained by the ratio of the area of the peak of this fatty acid relative to the sum of the areas of all the peaks pinpointed on the chromatogram, from lauric acid (C12:0) to DHA (C22:6 Δ4c, 7c, 10c, 13c, 16c, 19c) inclusive, with the methyl heptadecanoate peak being excluded.
  • The phospholipids are analyzed after disruption and cold extraction of the biomass, carried out under the following conditions.
  • Disruption of the Biomass
  • Precisely 200 mg of fresh biomass are weighed into a screw-top Pyrex tube. About 1-1.5 cm of glass beads (Retsch, reference 22.222.0003) and 0.1 ml of methanol are added. The tube is hermetically closed and stirred by means of a vortex mixer for at least 5 min.
  • Cold Extraction
  • Precisely 2 mg of triphenyl phosphate (purity≧98%) are weighed into a small aluminum boat using a microgram balance.
  • The boat is placed in a Pyrex NMR tube 5 mm in diameter along with 0.9 ml of methanol and 2 ml of chloroform. The tube is hermetically closed and stirred by means of a vortex mixer for 1 min.
  • The tube is placed in the refrigerator. After settling out (minimum of 1 hour), the clear upper phase is carefully recovered and is transferred into a glass jar for evaporation to dryness, at ambient temperature, under a nitrogen stream.
  • The solid extract is dissolved in 0.5 ml of CDCl3 and 0.1 ml of CD3OD and transferred into an NMR tube.
  • In order to express the phospholipid content on the basis of the phosphorus content obtained by NMR, the phosphorus provided by the four main phospholipids is taken into account and oleic acid is used to calculate the molar mass of each of them.
  • The phospholipid content is equal to the sum of the amounts of these four phospholipids thus calculated. The biomasses analyzed according to these methods (in the following Tables 9 and 10), in addition to that of the invention, are biomasses sold by Aquafauna Bio-Marine Inc., DSM/Martek and New Horizon.
  • TABLE 9
    Biomass in
    accordance OMEGA VIE
    with ALGAMAC NEW
    Total fatty acids in g/100 g crude and example 2 3050 DHA Gold HORIZON
    as % relative to total fatty acids g/100 g % g/100 g % g/100 g % g/100 g %
    Lauric C12:0 0.1 0.2 0.2 0.3 0.2 0.3 <0.1 0.1
    Myristic C14:0 2.9 5.4 5.4 10.1 6.1 10.8 1 2.7
    Pentadecylic C15:0 0.3 0.5 0.2 0.4 0.2 0.4 <0.1 0.2
    Palmitic C16:0 24.3 44.5 12.0 22.3 12.9 23.1 17.4 47.6
    Palmitoleic C16:1 Δ9c 0.1 0.3 0.1 0.2 0.1 0.2 <0.1 0.2
    Stearic C18:0 0.8 1.4 0.3 0.5 0.3 0.5 0.6 1.6
    Oleic C18:1 Δ9c w9 <0.03 <0.03 <0.03 0.2 0.5
    Linoleic (LA) C18:2 Δ9c, 12c w6 <0.1 <0.1 <0.03 <0.03 0.2 0.5
    g-linolenic (GLA) C18:3 Δ6c, 9c, 12c w6 <0.1 <0.1 0.1 0.2 0.1 0.2 <0.03 —
    a-linolenic (ALA) C18:3 Δ9c, 12c, 15c w3 <0.1 0.1 <0.1 <0.1 <0.1 <0.1 0.1 0.3
    Arachidic C20:0 <0.1 0.1 <0.1 0.1 <0.1 0.1 <0.1 0.1
    Stearidonic (SDA, STD) 0.1 0.2 0.2 0.3 0.2 0.3 <0.1 0.2
    C18:4 Δ6c, 9c, 12c, 15c w3
    Gondoic C20:1 Δ11c w9 <0.03 <0.03 <0.03 <0.03 —
    Dihomo-gamma-linolenic acid (DGLA) <0.1 0.1 0.2 0.3 0.2 0.3 <0.1 0.1
    C20:3 Δ8c, 11c, 14c w6
    Arachidonic (AA) C20:4 Δ5c, 8c, 11c, 14c w6 <0.1 0.1 0.2 0.4 0.2 0.4 <0.1 0.1
    (ETE) C20:3 Δ11c, 14c, 17c w3 <0.03 <0.03 <0.03 <0.03 —
    Behenic C22:0 <0.1 0.1 0.1 0.2 0.1 0.2 <0.1 0.1
    Timnodonic EPA 0.2 0.3 0.6 1.0 0.6 1.0 0.2 0.6
    C20:5 Δ5c, 8c, 11c, 14c, 17c w3
    Lignoceric C24:0 <0.03 0.1 0.2 0.1 0.2 <0.03 —
    Osbond acid C22:5 Δ4c, 7c, 10c, 13c, 16c w6 4.3 7.9 8.1 15 8.0 14.3 2.7 7.4
    Nervonic C24:1 Δ15c w9 <0.1 <0.1 0.1 0.2 0.1 0.2 <0.03 —
    Clupanodonic DPA <0.1 0.1 0.2 0.3 0.2 0.3 <0.1 0.1
    C22:5 Δ7c, 10c, 13c, 16c, 19c w3
    Cervonic DHA 19.2 35.2 23.6 43.9 24.3 43.3 12.8 35
    C22:6 Δ4c, 7c, 10c, 13c, 16c, 19c w3
    Others <3.4 <4.1 <3.9 2.6
    Total fatty acids 53 52 54
  • TABLE 10
    OMEGA
    Biomass in accordance with VIE
    the invention according to ALGAMAC DHA NEW
    example 1 3050 GOLD HORIZON
    Phospholipids in g/100 g crude, 1.6 0.8 0.9 0.6
    base C18:1
    Phosphatidylcholine as %/crude 1.1 0.6 0.7 0.5
    Lysophosphatidylcholine as %/crude 0.2 0.1 0.1 0.1
    Phosphatidylethanolamine as %/crude 0.3 0.1 0.1 <0.1
    Phosphatldyiglycerol as %/crude <0.1 <0.1 0 <0.1
    Dry matter in g/100 g 99.1 98.0 98.5 97.2
    Ash in g/100 g crude 6.4 9.5 10.0
    Nitrogen N6.25 in g/100 g crude 16.7 12.4 13.2 3.6
  • It appears, on reading the results presented here, that relative to the fatty acids profile:
      • the biomass according to the invention has a DHA content slightly lower than that of the commercial DHA-rich biomasses, but a palmitic acid content which is double, which constitutes as it were the fingerprint of the biomass of Schizochytrium mangrovei of the invention;
      • compared with commercial oils that have an equivalent DHA content and palmitic acid content, the biomass according to the invention has double the content of phospholipids (more particularly of phosphatidylcholine); and
      • a much higher amino nitrogen content.

Claims (14)

1-11. (canceled)
12. A strain of Schizochtrium mangrovei deposited on Nov. 22, 2012 at the CNCM under number I-4702.
13. A lipid rich biomass of microalga strain Schizochtrium mangrovei deposited on Nov. 22, 2012 at the CNCM under number 1-4702, comprising at least one of docosahexaenoic acid (or DHA) and palmitic acid.
14. The biomass according to claim 13, comprising docosahexaenoic acid (or DHA) and palmitic acid.
15. The biomass according to claim 14, comprising between 35 and 40% of DHA, and between 40 and 50 wt % of palmitic acid, respectively expressed by weight of total fatty acids.
16. The biomass according to claim 15, further comprising between 1.5 and 2% of phospholipids, expressed by weight of biomass at 99% of dry matter.
17. The biomass according to claim 16, comprising a total amino acids content of between 10 and 20% expressed as Nx6.25, the percentage being expressed by weight of biomass.
18. A food product or supplement, comprising the biomass according to claim 16, for consumption by humans or animals.
19. The biomass according to claim 13, comprising, between 35 and 40% of DHA and between 40 and 50 wt % of palmitic acid, expressed by weight of total fatty acids, and between 1.5 and 2% of phospholipids, expressed by weight of biomass at 99% of dry matter.
20. A food product comprising a biomass produced by the method of claim 13.
21. The food product as claimed in claim 20, wherein said biomass comprises:
between 35 and 40% of DHA and between 40 and 50 wt % of palmitic acid, expressed by weight of total fatty acids, and between 1.5 and 2% of phospholipids, expressed by weight of biomass at 99% of dry matter.
22. The biomass according to claim 13, comprising more than 35% of DHA and more than 40% of palmitic acid, respectively expressed by weight of total fatty acids, and between 1 and 1.3% of phosphatidylcholine, expressed by weight of biomass at 99% of dry matter.
23. A lipid rich biomass comprising, between 35 and 40% of docosahexaenoic acid, between 40 and 50 wt % of palmitic acid, less than 6 wt.% of lauric and myristic acids, each respectively expressed by weight of total fatty acids, and between 1.5 and 2% of phospholipids, expressed by weight of biomass at 99% of dry matter.
24. The biomass according to claim 23, wherein 1 to 1.3% of said phospholipids comprise phosphatidylcholine.
US15/722,563 2013-02-06 2017-10-02 Biomass of the microalgae schizochytrium mangrovei and method for preparing same Abandoned US20180016605A1 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
US15/722,563 US20180016605A1 (en) 2013-02-06 2017-10-02 Biomass of the microalgae schizochytrium mangrovei and method for preparing same

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
FR1351017A FR3001736B1 (en) 2013-02-06 2013-02-06 BIOMASS OF MICROALGUE SCHIZOCHYTRIUM MANGROVEI AND METHOD FOR PREPARING THE SAME
FR1351017 2013-02-06
PCT/EP2014/052214 WO2014122158A1 (en) 2013-02-06 2014-02-05 Biomass of the microalgae schizochytrium mangrovei and method for preparing same
US201514766141A 2015-08-06 2015-08-06
US15/722,563 US20180016605A1 (en) 2013-02-06 2017-10-02 Biomass of the microalgae schizochytrium mangrovei and method for preparing same

Related Parent Applications (2)

Application Number Title Priority Date Filing Date
PCT/EP2014/052214 Division WO2014122158A1 (en) 2013-02-06 2014-02-05 Biomass of the microalgae schizochytrium mangrovei and method for preparing same
US14/766,141 Division US9816116B2 (en) 2013-02-06 2014-02-05 Biomass of the microalgae Schizochytrium mangrovei and method for preparing same

Publications (1)

Publication Number Publication Date
US20180016605A1 true US20180016605A1 (en) 2018-01-18

Family

ID=48170722

Family Applications (2)

Application Number Title Priority Date Filing Date
US14/766,141 Active US9816116B2 (en) 2013-02-06 2014-02-05 Biomass of the microalgae Schizochytrium mangrovei and method for preparing same
US15/722,563 Abandoned US20180016605A1 (en) 2013-02-06 2017-10-02 Biomass of the microalgae schizochytrium mangrovei and method for preparing same

Family Applications Before (1)

Application Number Title Priority Date Filing Date
US14/766,141 Active US9816116B2 (en) 2013-02-06 2014-02-05 Biomass of the microalgae Schizochytrium mangrovei and method for preparing same

Country Status (8)

Country Link
US (2) US9816116B2 (en)
EP (1) EP2954072B1 (en)
JP (1) JP2016509483A (en)
KR (1) KR102202287B1 (en)
CN (1) CN104968779A (en)
CA (1) CA2899231C (en)
FR (1) FR3001736B1 (en)
WO (1) WO2014122158A1 (en)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR3031984B1 (en) * 2015-01-27 2019-05-24 Roquette Freres PROCESS FOR ENRICHING THE BIOMASS OF MICROALGUES OF THE GENUS TRAUSTOCHYTRIUM IN DHA AND IN AMINO ACIDS ARG AND GLU
KR101777217B1 (en) * 2015-09-15 2017-09-11 한국생명공학연구원 Microalgae Schizochytrium sp. SH103 strain producing bio-oil containing high concentration of DHA and uses thereof
WO2017131188A1 (en) * 2016-01-28 2017-08-03 日本水産株式会社 Production method for fats and oils containing highly unsaturated fatty acid
GB201701014D0 (en) * 2017-01-20 2017-03-08 Megatech Res Gmbh Composition and method of production thereof
CN109938193A (en) 2017-12-20 2019-06-28 罗盖特公司 DHA biomass, ARA residue and corn protein powder are used for the application of white shrimp feed
EP3852544A4 (en) 2018-09-21 2022-07-06 Heliae Development LLC Compositions and methods for introduction of odd-chain fatty acids into poultry eggs
EP4198136A3 (en) 2021-12-16 2023-08-30 Indian Oil Corporation Limited Methods and formulations for enhancing high value lipids
CN116555362A (en) 2022-01-29 2023-08-08 罗盖特公司 Method for producing lipids using yarrowia lipolytica

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996033263A1 (en) * 1995-04-17 1996-10-24 JAPAN, represented by DIRECTOR-GENERAL OF AGENCY OF INDUSTRIAL SCIENCE AND TECHNOLOGY Novel microorganisms capable of producing highly unsaturated fatty acids and process for producing highly unsaturated fatty acids by using the microorganisms
CA2639071A1 (en) * 2005-12-16 2007-06-21 Avesthagen Limited Docosahexaenoic acid (dha) producing thraustochytrid strain - sc1
CA2659603C (en) 2006-08-01 2017-03-07 Ocean Nutrition Canada Limited Oil producing microbes and methods of modification thereof
JP5731982B2 (en) * 2008-10-14 2015-06-10 ソラザイム, インコーポレイテッドSolazyme Inc Food composition of microalgal biomass
CN102839129A (en) * 2011-06-23 2012-12-26 法国罗凯特兄弟公司 Fragmentation chytrid mutagenesis method and variant produced by fragmentation chytrid mutagenesis method
EP2732025A4 (en) * 2011-07-13 2015-07-15 Alltech Inc Algal lipid compositions and methods of preparing and utilizing the same

Also Published As

Publication number Publication date
JP2016509483A (en) 2016-03-31
US9816116B2 (en) 2017-11-14
FR3001736A1 (en) 2014-08-08
CN104968779A (en) 2015-10-07
KR20150112976A (en) 2015-10-07
EP2954072A1 (en) 2015-12-16
CA2899231C (en) 2021-05-25
US20160145656A1 (en) 2016-05-26
EP2954072B1 (en) 2016-11-16
KR102202287B1 (en) 2021-01-13
FR3001736B1 (en) 2016-03-04
CA2899231A1 (en) 2014-08-14
WO2014122158A1 (en) 2014-08-14

Similar Documents

Publication Publication Date Title
US9816116B2 (en) Biomass of the microalgae Schizochytrium mangrovei and method for preparing same
ES2362476T3 (en) PROCESS TO PREPARE DOCOSAHEXANOIC ACID AND DOCOSAPENTANOIC ACID.
US9476075B2 (en) Oil enriched with arachidonic acid of microorganisms (unicellular fungus Mortierella alpina) and method for the production thereof
DK0957173T4 (en) Process for preparing fat or oil containing unsaturated fatty acid
WO2006022356A1 (en) Process for producing microorganism fat containing diacylglycerol in any amount and the fat
US20110129884A1 (en) Method for the cultivation of microorganisms of the order thraustochytriales
WO2011108755A1 (en) Method of producing lauric acid-containing oil or fat
KR20050053663A (en) Process for production of transesterified oils/fats or triglycerides
Akpinar-Bayizit et al. Single cell oil (SCO) production by Fusarium species using cheese whey as a substrate
WO2018097931A1 (en) Extraction of free dha from algal biomass
KR20070046143A (en) Process for producing triglyceride containing three residues of one highly unsaturated fatty acid and use thereof
KR20240107132A (en) Compositions and methods for producing fragrance
Yamada et al. Biotechnological processes for production of poly-unsaturated fatty acids
Praharyawan et al. Characterization of lipid productivity and fatty acid profile of three fast-growing microalgae isolated from Bengkulu for possible use in health application
JP4036595B2 (en) Lipids containing n-4 and / or n-7 polyunsaturated fatty acids and method for producing the same
JP5903214B2 (en) Method for producing DHA-containing phosphatidylserine by microbial fermentation
Zarea ISOLATION AND CHARACTERIZATION OF OLEAGINOUS MARINE YEAST PRODUCING OF FATTY ACIDS
JP2022000509A (en) Lipid composition, its use and its production method
BR102015018119A2 (en) PROCESS OF BIOMASS RICH PRODUCTION IN PIGS FOR USE IN ANIMAL NUTRITION AND / OR FISH EMPLOYING AGRICULTURAL WASTE AMILACE
JP2006340733A (en) Lipid containing n-4 system and/or n-7 system highly unsaturated fatty acids and method for producing the same

Legal Events

Date Code Title Description
STPP Information on status: patent application and granting procedure in general

Free format text: DOCKETED NEW CASE - READY FOR EXAMINATION

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: RESPONSE TO NON-FINAL OFFICE ACTION ENTERED AND FORWARDED TO EXAMINER

STPP Information on status: patent application and granting procedure in general

Free format text: NON FINAL ACTION MAILED

STPP Information on status: patent application and granting procedure in general

Free format text: FINAL REJECTION MAILED

STCB Information on status: application discontinuation

Free format text: ABANDONED -- FAILURE TO RESPOND TO AN OFFICE ACTION